1-Bromo-3,5-dimethoxybenzene | CAS:20469-65-2

We serve 1-Bromo-3,5-dimethoxybenzene CAS:20469-65-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-3,5-dimethoxybenzene

Chemical Name:1-Bromo-3,5-dimethoxybenzene
CAS.NO:20469-65-2
Synonyms:1-Bromo-3,5-dimethoxybenzene
benzene,1-bromo-3,5-dimethoxy
1,3-dimethoxy-5-bromobenzene
3,5-dimethoxy-1-bromobenzene
3,5-diMethoxy broMobenzene
3,5-dimethoxyphenyl-1-rbromobenzene
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 246.0±20.0 °C at 760 mmHg
Melting Point 62-66ºC
Molecular Formula C8H9BrO2
Molecular Weight 217.060
Flash Point 103.1±17.3 °C
 
Specification:
Appearance:White to yellow or light red powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:1-Bromo-3,5-dimethoxybenzene is used as an intermediate in the synthetic preparation of pharmaceutical inhibitors via cross-coupling reactions.



Contact us for information like 1-Bromo-3,5-dimethoxybenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-dimethoxyphenyl-1-rbromobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-dimethoxyphenyl-1-rbromobenzene Use and application,benzene,1-bromo-3,5-dimethoxy technical grade,usp/ep/jp grade.


Related News: The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China.4,6-dichloropyridazine-3-carboxylic acid manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.3-Bromo-2,6-dimethylpyridine supplier There are also new directives that relate to US citizens.3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid vendor ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.